- Home
- Applications
- vaccine producing
Show results for
Refine by
Vaccine Producing Product Applications
4 applications found
Real-time Viral Titer Assay Capability. Current viral titer assay methods, a crucial component of vaccine & CGT development and production efforts, are generally slow, labor intensive, subjective, and difficult to standardize, often resulting in large errors or failures during critical production ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. ...
By2A Pharma ApS based in Aalborg Øst, DENMARK
Clinics and physicians rely on manufacturers to ensure drug efficacy of active pharmaceutical ingredients (APIs) and sterility assurance across the supply chain—for the health and safety of their patients. As a manufacturer, we understand that your choice of sterilization modality is unique. Enhancing the aseptic manufacture sterility assurance level (SAL) of pharmaceuticals without affecting drug efficacy is a critical requirement of terminal ...
BySterigenics U.S., LLC based in Oak Brook, ILLINOIS (USA)
Vaccine manufacturing has been widely popular ever since Pasteur developed the rabies vaccine in 1885. Since then vaccine manufacturing has continued to be popular due to the defense that vaccines provide against certain viruses. The human immune system is constantly defending itself against a barrage of viruses and we simply lack the capacity to recognize and fight against these ever changing pathogens. Vaccines are designed to help mobilize the host’s immune system to prevent virus infections and break the ...
ByLonza Group Ltd based in Basel, SWITZERLAND